Zhao W - Search Results

1

Genomic and transcriptomic characterization reveals B-cell hyperactivation and immune evasion in hepatitis B virus-associated diffuse large B-cell lymphoma.

Qin W, Wang N, Shi Q, Sun R, Zheng Z, Fu D, Dong L, Li C, Zhang Y, Xu P, Cheng S, Qian Y, Feng Y, Wang L, Zhao W. Qin W, et al. Among authors: zhao w. Clin Transl Med. 2023 Jun;13(6):e1293. doi: 10.1002/ctm2.1293. Clin Transl Med. 2023. PMID: 37288581 Free PMC article. No abstract available.

2

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.

Liu YY, Leboeuf C, Shi JY, Li JM, Wang L, Shen Y, Garcia JF, Shen ZX, Chen Z, Janin A, Chen SJ, Zhao WL. Liu YY, et al. Blood. 2007 Jul 1;110(1):339-44. doi: 10.1182/blood-2006-09-049189. Epub 2007 Mar 22. Blood. 2007. PMID: 17379744 Free article.

3

[Expression of tumor suppressor gene PRDM1 in lung cancers].

Liu YY, Yang SJ, Ma J, Wang L, Liu YH, Chen SJ, Shen ZX, Zhao WL. Liu YY, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):434-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974277 Chinese.

4

[Analysis of overexpression of vascular endothelial growth factor-C in patients with angioimmunoblastic T-cell lymphoma].

Zhao WL, Liu YY, Plassa F, Jin XL, Wang L, Janin A, Shen ZX. Zhao WL, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):664-6. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399170 Chinese.

5

Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia/lymphoma.

Shi WY, Wang L, Xiao D, Yao Y, Yang F, Jiang XX, Leboeuf C, Janin A, Chen SJ, Zhao WL. Shi WY, et al. Ann Hematol. 2011 Jan;90(1):53-8. doi: 10.1007/s00277-010-1022-1. Epub 2010 Jul 9. Ann Hematol. 2011. PMID: 20617436

6

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.

Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A. Wang L, et al. J Hematol Oncol. 2010 Sep 9;3:30. doi: 10.1186/1756-8722-3-30. J Hematol Oncol. 2010. PMID: 20828385 Free PMC article.

7

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL. Xu PP, et al. Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710236

8

[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia].

Zhao BB, Zhu Z, Xu PP, Li JM, Shen ZX, Zhao WL, Wang L. Zhao BB, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):3-7. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23597455 Chinese.

9

[Study of prognostic related factors of elderly patients with T/NK cell lymphoma].

Wang Y, Qian Y, Wu LL, Zhao BB, Xu PP, Zhao WL, Wang L. Wang Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):12-5. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23597457 Chinese.

10

Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma.

Dong LH, Cheng S, Zheng Z, Wang L, Shen Y, Shen ZX, Chen SJ, Zhao WL. Dong LH, et al. J Hematol Oncol. 2013 Jul 18;6:53. doi: 10.1186/1756-8722-6-53. J Hematol Oncol. 2013. PMID: 23866964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,046 results

Search Page

Filters